Is the Duration of Adjuvant Trastuzumab Debate Still Clinically Relevant?
The Lancet- United Kingdom
doi 10.1016/s0140-6736(19)30946-8
Full Text
Abstract
Available in
Categories
Date
June 1, 2019
Authors
Publisher
Elsevier BV
doi 10.1016/s0140-6736(19)30946-8
Available in
June 1, 2019
Elsevier BV